Evaluation of the GenoType® MTBDRplus assay and identification of a rare mutation for improving MDR-TB detection

International Journal of Tuberculosis and Lung Disease

Volumn 16, Issue 4, 2012, Pages 521-526

  Jin, J ^a   Zhang, Y ^a,b   Fan, X ^a   Diao, N ^a   Shao, L ^a   Wang, F ^a   Hu, P ^c   Wang, S ^a   Weng, X ^a   Zhang, Wenhong ^a,d  

^a FUDAN UNIVERSITY   (China)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c Chongqing Pulmonary Hospital   (China)

^d FUDAN UNIVERSITY   (China)

Author keywords

GenoType ; KatG; MDR TB; MTBDRplus assay; Mycobacterium tuberculosis

Indexed keywords

ISONIAZID; RIFAMPICIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM DETECTION; CHINA; CONTROLLED STUDY; DNA SEQUENCE; GENE MUTATION; GENOTYPE; INHA GENE; INTERMETHOD COMPARISON; KATG GENE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; RPOB GENE; SENSITIVITY AND SPECIFICITY;

ANTITUBERCULAR AGENTS; CHINA; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENOTYPE; HUMANS; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MOLECULAR DIAGNOSTIC TECHNIQUES; MUTATION; MYCOBACTERIUM TUBERCULOSIS; RIFAMPIN; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84863374017     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.11.0269     Document Type: Article

References (26)

1. Tenover F C, Crawford J T, Huebner R E, Geiter L J, Horsburgh C R Jr, Good R C. The resurgence of tuberculosis: is your laboratory ready? J Clin Microbiol 1993; 31: 767-770. (Pubitemid 23086511)
2. Ahmad S, Mokaddas E. Recent advances in the diagnosis and treatment of multidrug-resistant tuberculosis. Respir Med 2009; 103: 1777-1790.
3. Telenti A, Imboden P, Marchesi F, et al. Detection of rifampicin resistance mutations in Mycobacterium tuberculosis. Lancet 1993; 341: 647-650. (Pubitemid 23083244)
4. Mokrousov I, Narvskaya O, Otten T, Limeschenko E, Steklova L, Vyshnevskiy B. High prevalence of KatG Ser315Thr substitution among isoniazid-resistant Mycobacterium tuberculosis clinical isolates from northwestern Russia, 1996 to 2001. Antimicrob Agents Chemother 2002; 46: 1417-1424. (Pubitemid 34415323)
5. Zhang Y, Heym B, Allen B, Young D, Cole S. The catalasep eroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 1992; 358: 591-593.
6. Banerjee A, Dubnau E, Quemard A, et al. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 1994; 263: 227-230. (Pubitemid 24067929)
7. Zhang Y, Yew W W. Mechanisms of drug resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2009; 13: 1320-1330.
8. Bang D, Bengard Andersen A, Thomsen V O. Rapid genotypic detection of rifampin- and isoniazid-resistant Mycobacterium tuberculosis directly in clinical specimens. J Clin Microbiol 2006; 44: 2605-2608. (Pubitemid 44092440)
9. Gamboa F, Cardona P J, Manterola J M, et al. Evaluation of a commercial probe assay for detection of rifampin resistance in Mycobacterium tuberculosis directly from respiratory and nonrespiratory clinical samples. Eur J Clin Microbiol Infect Dis 1998; 17: 189-192. (Pubitemid 28306267)
10. Hillemann D, Weizenegger M, Kubica T, Richter E, Niemann S. Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates. J Clin Microbiol 2005; 43: 3699-3703. (Pubitemid 41129648)
11. Tortoli E, Marcelli F. Use of the INNO LiPA Rif.TB for detection of Mycobacterium tuberculosis DNA directly in clinical specimens and for simultaneous determination of rifampin susceptibility. Eur J Clin Microbiol Infect Dis 2007; 26: 51-55. (Pubitemid 46089582)
12. Dubois N, Ramarokoto H, Ravololonandriana P, Richard V, Rasolofo V. DNA extracted from stained sputum smears can be used in the MTBDRplus assay. J Clin Microbiol 2011; Aug 10. [Epub ahead of print]
13. Kim S J. Drug susceptibility testing in tuberculosis: methods and reliability of results. Eur Respir J 2005; 25: 564-569. (Pubitemid 40331189)
14. Ramaswamy S V, Reich R, Dou S J, et al. Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2003; 47: 1241-1250. (Pubitemid 36372035)
15. Ling D I, Zwerling A A, Pai M. GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a metaanalysis. Eur Respir J 2008; 32: 1165-1174.
16. Marrakchi H, Laneelle G, Quemard A. InhA, a target of the antituberculous drug isoniazid, is involved in a mycobacterial fatty acid elongation system, FAS-II. Microbiology 2000; 146 (Pt 2): 289-296. (Pubitemid 30099203)
17. Mdluli K, Slayden R A, Zhu Y, et al. Inhibition of a Mycobacterium tuberculosis beta-ketoacyl ACP synthase by isoniazid. Science 1998; 280: 1607-1610. (Pubitemid 28277706)
18. Kelley C L, Rouse D A, Morris S L. Analysis of ahpC gene mutations in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother 1997; 41: 2057-2058. (Pubitemid 27383260)
19. Wilson T, de Lisle G W, Marcinkeviciene J A, Blanchard J S, Collins D M. Antisense RNA to ahpC, an oxidative stress defence gene involved in isoniazid resistance, indicates that AhpC of Mycobacterium bovis has virulence properties. Microbiology 1998; 144 (Pt 10): 2687-2695. (Pubitemid 28486418)
20. Müller B, Streicher E M, Hoek K G P, et al. inhA promoter mutations: a gateway to extensively drug-resistant tuberculosis in South Africa? Int J Tuberc Lung Dis 2011; 15: 344-351.
21. Campbell P J, Morlock G P, Sikes R D, et al. Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis. Antimicrob Agents Chemother 2011; 55: 2032-2041.
22. Barnard M, Albert H, Coetzee G, O'Brien R, Bosman M E. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am J Respir Crit Care Med 2008; 177: 787-792. (Pubitemid 351490566)
23. Ortona L, Cingolani A. Genetics of Mycobacterium tuberculosis and genotyping of drug resistance. Rays 1998; 23: 42-47. (Pubitemid 28283585)
24. Li G L, Zhao D F, Xie T, et al. Molecular characterization of drug-resistant Beijing family isolates of Mycobacterium tuberculosis from Tianjin, China. Biomed Environ Sci 2010; 23: 188-193.
25. Luo T, Zhao M, Li X, et al. Selection of mutations to detect multidrug-resistant Mycobacterium tuberculosis strains in Shang hai, China. Antimicrob Agents Chemother 2010; 54: 1075-1081.
26. World Health Organization. Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response. WHO/HTM/TB/2010.3. Geneva, Switzerland: WHO, 2010.